233 related articles for article (PubMed ID: 33413231)
41. CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2.
Xiao G; Wang X; Yu Y
Cell Physiol Biochem; 2017; 43(2):840-851. PubMed ID: 28954272
[TBL] [Abstract][Full Text] [Related]
42. Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells.
Jiang PH; Motoo Y; Sawabu N; Minamoto T
World J Gastroenterol; 2006 Mar; 12(10):1597-602. PubMed ID: 16570353
[TBL] [Abstract][Full Text] [Related]
43. [A novel chemo-resistant gene MSX2 discovered by establishment of two pancreatic cancer drug resistant cell lines JF305/CDDP and PANC-1/GEM].
Yuan W; Sui CG; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):330-334. PubMed ID: 29860758
[No Abstract] [Full Text] [Related]
44. Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease.
Al-Shaibi AA; Abdel-Motal UM; Hubrack SZ; Bullock AN; Al-Marri AA; Agrebi N; Al-Subaiey AA; Ibrahim NA; Charles AK; ; Elawad M; Uhlig HH; Lo B
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1809-1830. PubMed ID: 34237462
[TBL] [Abstract][Full Text] [Related]
45. Binding of anterior gradient 2 and estrogen receptor-α: Dual critical roles in enhancing fulvestrant resistance and IGF-1-induced tumorigenesis of breast cancer.
Li Z; Zhu Q; Chen H; Hu L; Negi H; Zheng Y; Ahmed Y; Wu Z; Li D
Cancer Lett; 2016 Jul; 377(1):32-43. PubMed ID: 27063095
[TBL] [Abstract][Full Text] [Related]
46. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S
Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909
[TBL] [Abstract][Full Text] [Related]
47.
Tadros S; Shukla SK; King RJ; Gunda V; Vernucci E; Abrego J; Chaika NV; Yu F; Lazenby AJ; Berim L; Grem J; Sasson AR; Singh PK
Cancer Res; 2017 Oct; 77(20):5503-5517. PubMed ID: 28811332
[TBL] [Abstract][Full Text] [Related]
48. The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42-44 MAPK, Akt, Bcl-2 and MMP13 pathways.
Tréhoux S; Duchêne B; Jonckheere N; Van Seuningen I
Biochem Biophys Res Commun; 2015 Jan; 456(3):757-62. PubMed ID: 25511698
[TBL] [Abstract][Full Text] [Related]
49. Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development.
Chevet E; Fessart D; Delom F; Mulot A; Vojtesek B; Hrstka R; Murray E; Gray T; Hupp T
Oncogene; 2013 May; 32(20):2499-509. PubMed ID: 22945652
[TBL] [Abstract][Full Text] [Related]
50. New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice.
Arumugam T; Deng D; Bover L; Wang H; Logsdon CD; Ramachandran V
Mol Cancer Ther; 2015 Apr; 14(4):941-51. PubMed ID: 25646014
[TBL] [Abstract][Full Text] [Related]
51. Anterior gradient 2 is a novel pro-tumor factor in pancreatic cancer under NF-κB subunit RelA trans-regulation that can be suppressed by eugenic acid.
Huang L; Yang C; Wang Y; Li G; Pan J; Luo H; Wu Z; Tian Y; Chen S; Chen J; Jian Z
Biomed Pharmacother; 2020 Dec; 132():110830. PubMed ID: 33059262
[TBL] [Abstract][Full Text] [Related]
52. Rab14 overexpression regulates gemcitabine sensitivity through regulation of Bcl-2 and mitochondrial function in pancreatic cancer.
Ge J; Ge C
Virchows Arch; 2019 Jan; 474(1):59-69. PubMed ID: 30267303
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression.
Tang K; Zhang Z; Bai Z; Ma X; Guo W; Wang Y
Oncol Rep; 2011 Apr; 25(4):963-70. PubMed ID: 21225236
[TBL] [Abstract][Full Text] [Related]
54. Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.
Tiemann K; Garri C; Lee SB; Malihi PD; Park M; Alvarez RM; Yap LP; Mallick P; Katz JE; Gross ME; Kani K
Oncogene; 2019 Apr; 38(16):3003-3018. PubMed ID: 30575818
[TBL] [Abstract][Full Text] [Related]
55. Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K/Akt/mTOR signaling pathway.
Zhou HY; Yao XM; Chen XD; Tang JM; Qiao ZG; Wu XY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10283-10289. PubMed ID: 31841183
[TBL] [Abstract][Full Text] [Related]
56. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
[TBL] [Abstract][Full Text] [Related]
57. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
Xu BQ; Fu ZG; Meng Y; Wu XQ; Wu B; Xu L; Jiang JL; Li L; Chen ZN
Oncotarget; 2016 Sep; 7(38):62177-62193. PubMed ID: 27556697
[TBL] [Abstract][Full Text] [Related]
58. Basic helix-loop-helix transcription factor Twist1 is a novel regulator of anterior gradient protein 2 homolog (AGR2) in breast cancer.
Jung SY; Yun J; Kim SJ; Kang S; Kim DY; Kim YJ; Park JH; Jang WB; Ji ST; Ha JS; Hong Van LT; Truong Giang LT; Rethineswaran VK; Kim DH; Song P; Kwon SM
Biochem Biophys Res Commun; 2019 Aug; 516(1):149-156. PubMed ID: 31202462
[TBL] [Abstract][Full Text] [Related]
59. hsa_circ_0119412 overexpression promotes cervical cancer progression by targeting miR-217 to upregulate anterior gradient 2.
Lv Y; Wang M; Chen M; Wang D; Luo M; Zeng Q
J Clin Lab Anal; 2022 Apr; 36(4):e24236. PubMed ID: 35274779
[TBL] [Abstract][Full Text] [Related]
60. WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells.
Wei W; Sun HH; Li N; Li HY; Li X; Li Q; Shen XH
Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):529-38. PubMed ID: 25308364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
